← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2014Last known activity
Nov 30, 2024
Timeline
2000s
- Jan 1, 2005
Neurocentria, Inc.— Founded
Drugs by trial phase (3 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT06673368Lead sponsorPhase 2Nov 30, 2024
- NCT06673368OfficialPhase 2Nov 30, 2024
- NCT06215144Lead sponsorPhase 2/Phase 3Jan 25, 2024
- NCT06215144OfficialPhase 2/Phase 3Jan 25, 2024
- NCT05683249Lead sponsorPhase 2/Phase 3Feb 25, 2023
- NCT05683249Study directorPhase 2/Phase 3Feb 25, 2023
- NCT03531684Lead sponsorPhase 2Mar 20, 2018
- NCT02558790CollaboratorPhase 2Mar 1, 2016
- NCT02237235CollaboratorPhase 4Aug 1, 2014
Details
- Founded
- Walnut Creek, CA, US Jan 1, 2005
- Last known activity
- Nov 30, 2024